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Abstract
BACKGROUND: Marfan syndrome (MFS) is a heritable disorder of connective tissue, affecting
principally skeletal, ocular, and cardiovascular systems. The most life-threatening manifestations are
aortic aneurysm and dissection. We investigated changes in the proteome of aortic media in patients
with and without MFS to gain insight into molecular mechanisms leading to aortic dilatation.
METHODS AND RESULTS: Aortic samples were collected from 46 patients. Twenty-two patients
suffered from MFS, 9 patients had bicuspid aortic valve, and 15 patients without connective tissue
disorder served as controls. Aortic media was isolated and its proteome was analyzed in 12 patients with
the use of 2-dimensional difference gel electrophoresis and mass spectrometry. We found higher
amounts of filamin A C-terminal fragment, calponin 1, vinculin, microfibril-associated glycoprotein 4,
and myosin-10 heavy chain in aortic media of MFS aneurysm samples than in controls. Regulation of
filamin A C-terminal fragmentation was validated in all patient samples by immunoblotting. Cleavage
of filamin A and the calpain substrate spectrin was increased in the MFS and bicuspid aortic valve
groups. Extent of cleavage correlated positively with calpain 2 expression and negatively with the
expression of its endogenous inhibitor calpastatin. CONCLUSIONS: Our observation demonstrates for
the first time upregulation of the C-terminal fragment of filamin A in dilated aortic media of MFS and
bicuspid aortic valve patients. In addition, our results present evidence that the cleavage of filamin A is
highly likely the result of the protease calpain. Increased calpain activity might explain, at least in part,
histological alterations in dilated aorta.
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ABSTRACT 
Background−Marfan syndrome (MFS) is a heritable disorder of connective tissue, 
affecting principally skeletal, ocular and cardiovascular systems. The most life-
threatening manifestations are aortic aneurysm and dissection. We investigated 
changes in the proteome of aortic media in patients with and without MFS to gain 
insight into molecular mechanisms leading to aortic dilatation.  
Methods and Results−Aortic samples were collected from 46 patients. Twenty-two 
patients suffered from MFS, 9 patients had bicuspid aortic valve (BAV) and 15 
patients without connective tissue disorder served as controls. Aortic media was 
isolated and its proteome analysed in 12 patients using two dimensional difference 
gel electrophoresis and mass spectrometry. We found higher amounts of filamin A 
C-terminal fragment, calponin 1, vinculin, microfibril associated glycoprotein 4 and 
myosin-10 heavy chain in aortic media of MFS aneurysm than in controls. Regulation 
of filamin A C-terminal fragmentation was validated in all patient samples by 
immunoblotting. Cleavage of filamin A and the calpain substrate spectrin were 
increased in the MFS and BAV group. Extent of cleavage correlated positively with 
calpain 2 expression and negatively with the expression of its endogenous inhibitor 
calpastatin. 
Conclusion−Our observation demonstrates for the first time up-regulation of the C-
terminal fragment of filamin A in dilated aortic media of MFS and BAV patients. In 
addition our results present evidence that the cleavage of filamin A is highly likely the 
result of the protease calpain. Increased calpain activity might explain, at least in 
part, histological alterations in dilated aorta.  
 
Key Words: aneurysm, aorta, calpain, Marfan syndrome, proteomics   
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INTRODUCTION 
Marfan syndrome (MFS) is a disorder of connective tissue caused by mutations in 
the fibrillin-1 gene (FBN-1) that may lead to abnormal regulation of transforming 
growth factor β (TGF-β) signalling.1 Clinical manifestation implies principally the 
cardiovascular, skeletal, and ocular systems while other systems such as skin, lung 
and dura may also be affected. Cardiovascular defects involve dilatation of the 
ascending aortic root leading to aortic aneurysm and dissection, the main cause of 
morbidity and mortality in MFS, and mitral valve prolapse with or without 
regurgitation.2 
Molecular mechanisms of aneurysm formation and its treatment are the subject of 
intensive research. Three key proteins seem to directly contribute to aneurysm 
formation. First, defective fibrillin-1 is thought to alter targeting and sequestration of 
TGF-β leading to increased TGF-β activity.1 Blocking TGF-β activity with antagonists 
such as TGF-β-neutralizing antibodies prevents aneurysm formation in a mouse 
model of MFS.3 Second, angiotensin (Ang) II is up-regulated in MFS.4 Treatment of 
patients with angiotensin II type 1 (AT1) receptor blocker or angiotensin-converting 
enzyme (ACE) inhibitors reduces progression of aortic dilation in MFS. 3, 5-7 
Attenuation of aortic remodelling by lowering Ang II levels can be mediated by TGF-β 
dependent and independent mechanisms.8 Third, proteases play a pivotal role in the 
pathology of aortic dilatation. We have profiled the activity of matrix 
metalloproteinases (MMPs) in MFS aortic aneurysms.9 Studies in the MFS mouse 
model revealed the up-regulation of MMP-2 and -9.10  
Calpains are another class of proteases not yet associated with MFS aortic 
aneurysm. Calpains are calcium dependent cysteine proteases that cleave many 
intracellular signalling and structural proteins. The two major isoforms, calpain 1 and 
calpain 2, are ubiquitously expressed and differ in their tertiary structure and Ca2+ 
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requirements.11 Activation of calpain is regulated by its endogenous inhibitor 
calpastatin, intracellular localization of the protease and local Ca2+ concentrations. 
Recent studies have implicated the calpain/calpastatin system in Ang II induced 
cardiovascular remodelling.12 Evidence exists that Ang II induces calpain expression 
and activity and further leads to up-regulation of MMP-2.12, 13 Since elevated Ang II 
levels and increased MMP-2 activity are elements in the initiation and progression of 
aortic aneurysms, the calpain/calpastatin system might play an important role in MFS 
aortic remodelling and dilatation.  
The aim of the current study was to investigate differences in the proteome of aortic 
media in patients with and without MFS to gain new insights into the pathologic 
mechanisms of aortic dilatation. Increased filamin A fragmentation in dilated aortic 
media of MFS and BAV patients led us further investigate the proteolytic 
calpain/calpastatin system.  
 
METHODS 
Source of Tissue 
Aneurysm tissue from ascending aorta was obtained from 22 MFS patients at the 
time of aortic root replacement and from 9 BAV patients. Ascending aorta of 15 non-
MFS and non-BAV patients without aortic dilation served as control group. Mainly 
heart transplant patients and patients suffering from tricuspid aortic valve stenosis, 
undergoing elective aortic valve replacement, were included. MFS diagnosis was 
based on the Gent criteria. In 6 patients genetic mutation analysis has been 
performed (for results see online-only data supplement). All Marfan patients had a 
tricuspid aortic valve. There were no differences in gender (controls: 67±13% male, 
MFS: 83±8% male, BAV: 67±17% male, p=0.4638). Mean age differed between MFS 
and controls (controls: 60±3 years, MFS: 38±4 years, p=0.0005) but not between 
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BAV and controls (BAV: 57±3 years, p=0.6131). Mean aortic diameter were similar in 
MFS and BAV (MFS: 4.99±0.12cm, BAV: 4.84±0.19cm, p=0.52) and different to 
controls (controls: <3.5cm, p<0.0001). Arterial hypertension was present in 14 
patients (controls: 27%, MFS: 36%, BAV: 22%), but was an independent variable 
(p=0.69). There was no significant difference in ACE and AT1 receptor blocker 
therapy in the three groups (controls: 27%, MFS: 14%, BAV: 11%, 
p=0.51).Treatment with beta-blockers was more common in the MFS group 
(controls: 33%, MFS: 73%, BAV: 33%, p=0.03).    
Written informed consent was obtained from all patients, according to local ethics 
committee approval of the University Hospital of Berne and the University of 
Pennsylvania. 
Aortic tissue was dissected into adventitia, media and intima. From each tissue, one 
section was immediately snap-frozen in liquid nitrogen and stored at –70°C until 
protein analysis. Another section was fixed with 4% paraformaldehyde in PBS for 
histological examination.  
 
Histology  
Fixed tissue was dehydrated in an automatic tissue processor, embedded in paraffin, 
and cut into 4µm sections for histochemical evaluation. Sections were stained with 
Verhoeff’s van Gieson protocol for evaluation of tissue separation.14  
 
2D – Differential Gel Electrophoresis 
Samples from 12 patients were used for proteomic analysis. For high resolution of 
proteins and minimal gel to gel variation 2-dimensional differential gel 
electrophoresis (2D-DIGE) was performed. Therefore proteins from aortic aneurysms 
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were labelled with different fluorophores than non-aneurysm proteins (Cy3 and Cy5). 
For details, please refer to the online-only data supplement.  
 
Image Analysis 
Labelled proteins were visualized using a Typhoon™ 9400 imager (GE Healthcare). 
Spot matching, quantification, and statistical analyses were performed using 
Proteomweaver software (Definiens AG, Munich, Germany). Scanned images were 
uploaded into the software and automated spot detection and quantification was 
performed. The software identified spot candidates by detecting local maxima in the 
gray-scale gel image, the outline of those was calculated using a downhill gradient 
flood-filling algorithm. The same spots in different gels were matched using a 
pattern-matching algorithm that depends on the spot’s features and the geometry 
and features of its neighbours. The spot quantification calculated the spot volume 
using the integral of a Gaussian approximation corrected by a factor that depends on 
the local background level. Normalized protein spots in the Cy3 and Cy5 images 
were compared with the internal standard (Cy2) to generate ratios of relative 
amounts. Protein spots were considered to be significantly differentially regulated 
when the t-test value was p<0.05 and the regulation factor >2. 
 
Mass Spectrometry 
For identification of differentially regulated protein spots, spot candidates were 
picked from the gel and trypsin digested. Eluted peptides were identified by matrix-
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
MS/MS) and liquid chromatography - mass spectrometry (LC-MS/MS). For details, 
please refer to the online-only data supplement.  
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Immunoblotting 
Protein cleavage and relative abundance of differentially expressed proteins was 
examined using Western blot technology. Briefly, 5µg of aortic media extracted in 
DIGE buffer was loaded onto a 10% polyacrylamide/SDS-gel and subjected to 
separation by electrophoresis. Proteins were electro-blotted onto PVDF membrane 
(Hybond, GE Healthcare). Antibodies against the C-terminus of filamin A, 
calpastatin, α-2 spectrin, β-actin (Santa Cruz Biotechnology, Santa Cruz, USA) and 
calpain 2 (Cell Signaling Technology, Danvers, USA) were used.  Positive 
immunoreactivity was detected with chemiluminescence substrate (ECL detection 
reagent, GE Healthcare) and exposure of the blots to film (Hyperfilm, GE 
Healthcare). After development, films were digitized and quantitative densitometric 
image analysis was performed (ImageJ 1.39C, rsbweb.nih.gov/ij/). Protein cleavage 
was assessed as the amount of cleavage fragment relative to the amount of full 
length protein. Cleavage of α-2 spectrin was used as a measure for calpain activity.15  
 
Statistics 
For statistical comparisons parametric (T-Test, Pearson) and non-parametric tests 
(Mann-Whitney, Spearman) were used. If more than two groups were compared 
ANOVA was applied. Pearsons chi-square test was considered for discrete data. 
Normal distribution was tested using D’Agostino & Pearson omnibus normality test. 
Values are given as mean±SEM. 
 
The authors had full access to the data and take responsibility for its integrity. All 
authors have read and agree to the manuscript as written.  
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RESULTS 
Histology  
Histology and quality of separation technique were investigated in aortic samples for 
proteomic analysis using van Gieson’s elastic stain (Figure 1). The tissue separation 
technology revealed well dissected media in control, MFS and BAV samples. 
Fragmentation of elastic fibres was present in media of MFS patients and to a lesser 
extent in BAV patients. 
   
Differentially Expressed Proteins in MFS Aortic Media 
Protein expression of aortic media from six randomly selected MFS aneurysm and 
six randomly selected controls were compared using 2D-DIGE. Each gel contained 
the aortic media proteome of MFS patients, control patients and an internal standard. 
Between 997 and 1247 protein spots were resolved according to the spot detection 
tool of the image analysis software. Six spots were found to be significantly up-
regulated in MFS aortic media while 20 protein spots were down-regulated more 
than twofold (p<0.05) (Figure 2). From the colloidal Coomassie stained gels 17 spots 
could be picked and subjected to mass spectrometry. Table 1 lists the identified 
protein spots as outlined in Figure 2. Details of mass spectrometric identification are 
summarized in Table I of the online-only Data Supplement. Up-regulated proteins 
were myosin-10 heavy chain (myo10), vinculin, filamin A (FlnA), microfibril 
associated glycoprotein 4 (MFAP 4) and calponin 1. Down-regulated proteins were 
vitamin-D binding protein (DBP), fructose-bisphosphate aldolase C, apolipoprotein 
A1 (Apo-A1), serum amyloid P (SAP), transgelin (SM22-alpha) and hemoglobin beta 
and alpha chain. Comparison of the molecular weight of separated proteins with 
theoretical values and analysis of the sequence coverage achieved by mass 
spectrometry revealed that FlnA was not up-regulated as an entire protein, however 
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as C-terminal fragment. Proteolysis was also observed for calponin 1. The entire 
protein with a MW of 33kDa was up-regulated as well as its fragment of 20kDa. The 
occurrence of fragmentation of these two proteins attracted our interest in relation to 
proteolytic activity of MFS media from aortic aneurysms.   
 
Filamin A C-terminal Fragment 
We confirmed the up-regulation of FlnA C-terminal fragment from proteomic analysis 
in the entire study population using Western blot. Using a specific antibody against 
the C-terminus of FlnA revealed bands at 280kDa, representing the full length 
protein, and bands at 90 and 110kDa, representing the fragments detected in our 
proteomic analysis (Figure 3). Comparison of the ratio of cleavage products to 
substrate revealed a significant up-regulation of FlnA cleavage in the MFS and BAV 
group compared to controls (controls: 2.04±0.21, MFS: 2.64±0.17, p<0.05 from 
controls, BAV: 3.04±0.21, p<0.01 from controls).     
 
Calpain 2 
Calpain 2 activity was assessed by measuring the cleavage fragments of α-2 
spectrin at 145/150kDa.15 We found a significantly up-regulated cleavage of α-2 
spectrin in aneurysmic aortic media compared to controls (controls: 0.70±0.08, MFS: 
1.05±0.09, p<0.05 from controls, BAV: 1.15±0.10, p<0.05 from controls). Sub-
population analysis in all patients revealed that hypertension did not result in 
elevated spectrin cleavage (see online-only data supplement). Furthermore, there 
was a strong correlation between FlnA and α-2 spectrin cleavage (r=0.92, p<0.0001, 
n=46), confirming that calpain 2 is involved in FlnA cleavage (Figure 4). 
Quantification of calpain 2 expression and its inhibitor calpastatin revealed a positive 
correlation of calpain 2 with FlnA (r=0.33, p=0.0258, n=46) and spectrin cleavage 
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(r=0.41, p=0.0052, n=46) and a negative correlation of calpastatin with FlnA 
(r=−0.31, p=0.0386, n=46) and spectrin cleavage (r=−0.43, p=0.0032, n=46). 
Interestingly the ratio of calpain 2 and its inhibitor calpastatin highly correlated with 
FlnA (r=0.47, p=0.0009, n=46) as well as with spectrin cleavage (r=0.60, p<0.0001, 
n=46).  
 
DISCUSSION 
Thoracic aortic aneurysms and aortic dissection are the major cause of premature 
death in MFS.2 Until recently, the common treatment methods for MFS aneurysms 
were live-long medication with β-blockers and repair of dilated aorta.16 New insights 
into molecular mechanisms of aortic dilatation in MFS have revealed that TGF-β, 
Ang II and MMPs are up-regulated, thus leading to new treatment options. 
Antagonism of TGF-β with neutralizing antibodies, blockage of AT1R with Losartan, 
inhibition of ACE by Perindopril and of MMP-2 and -9 by Doxycycline showed 
attenuation of aortic root dilation and reduced TGF-β activity in aortic media of mice 
and humans. 3, 6, 17 
In the current study, we analysed aortic media to explore new molecular alterations 
associated with thoracic aortic aneurysms in MFS. We used 2D-DIGE to detect 
differences in protein abundance and mass spectrometry for subsequent protein 
identification. To minimize contamination of the aortic proteome by blood cells or 
plasma proteins, and to investigate the aortic tunica that is mostly involved in the 
pathogenesis of aneurysm formation, we dissected the aorta and only analyzed 
aortic media for differential regulation.  
Most interesting was the finding that the FlnA C-terminal fragmentation is up-
regulated in aortic media of MFS and BAV patients. Intact FlnA is a high MW protein 
that cross-links and organizes actin filaments into parallel arrays of three-
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dimensional webs. In addition, FlnA interacting proteins such as TGF-β receptor-
activated Smads, that bind to the C-terminus, are important signalling molecules.18, 19 
Mutations in FlnA are responsible for familial cardiac valvular dystrophy and aortic 
aneurysms in periventricular nodular heterotopia.20, 21 Furthermore, filamin gene 
expression in mitral valves in a mouse model of MFS is significantly increased in 
homozygote animals.22 
The C-terminal region of FlnA, which we found to be up-regulated in MFS and BAV 
aneurysm media, reveals other functions than the intact protein. The fragment itself 
has the capacity to translocate to the nucleus together with the androgen receptor, 
resulting in the repression of androgen receptor transcriptional activity.23, 24 
Moreover, FlnA C- terminal fragments as well as the spectrin fragment, have recently 
been proposed as parts of biomarker panels. The FlnA C-terminal fragment was 
secreted from aorta that underwent arterial wall remodelling.25 Increased spectrin 
fragments where found in cerebrospinal fluid of patients with mild central nervous 
system injury .26  
FlnA is cleaved by the proteases calpain, caspase and granzyme B.27, 28 Evaluating  
caspase 3 and granzyme B activity in a subset of patients showed no difference 
between normal aorta and MFS aneurysm (data not shown), whereas calpain did. 
Calpain activity was assessed by measuring cleavage of its endogenous substrate 
spectrin. We found increased cleavage of spectrin in MFS and BAV aortic aneurysm 
that highly correlated with the increase of FlnA cleavage. Furthermore, increase of 
spectrin and FlnA proteolysis correlated with increasing calpain expression and 
decreasing expression of its inhibitor calpastatin. Due to the high correlation between 
spectrin and FlnA cleavage in the absence of increased activity of caspase 3 and 
granzyme B, we conclude that both proteolytic digestions result from the action of 
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calpain, which is attributable to higher protease expression as well as lowered 
expression of its inhibitor. 
Increased activity of calpain is known from different pathological states such as from 
cardiovascular remodelling following Ang II induced hypertension and from aging.12, 
13 Recently, Letavernier et al demonstrated that infusion of Ang II in mice resulted in 
increased calpain and decreased calpastatin expression.12 The group further showed 
that over expression of the inhibitor calpastatin decreased MMP-2 and -9 activity and 
attenuated Ang II induced vascular remodelling with focus on hypertrophy, 
perivascular inflammation and tissue fibrosis.12 Interestingly administration of 
Losartan restored basal calpain levels. Losartan therefore offers a pharmacological 
approach to reduce excessive activity of calpain. Furthermore, TGF-β induced 
apoptosis in rat hepatocytes was greatly attenuated by inhibiting calpain 1 and more 
efficiently by inhibiting calpain 2.29, 30 Thus, calpain inhibition might potentially also 
attenuate TGF-β activity. 
Ang II mRNA expression in MFS aortic aneurysm and Ang II concentrations 
measured by ELISA were elevated compared to controls.4 Confirming this, 
antagonism of Ang II with the AT1R blocker Losartan, or ACE inhibitors, blunt aortic 
dilatation and decrease TGF-β activation.3, 4, 6 Ang II also stimulates Smad 2-
dependent signalling and fibrosis in vascular smooth muscle cells (VSMCs) in a 
TGF-β independent manner, an effect prevented by selective AT1R blockade.
8 Thus, 
we speculate that calpain plays a role in TGF-β dependent and independent Smad 
activation in the setting of increased Ang II concentrations.  
Calpain is activated by mechanical stress. This observation was detected when 
VSMC were subjected to mechanical stress. Increased calpain activation seemed to 
counteract VSMC apoptosis by degradation of p53.31 Since the same group detected 
an increase in expression and activity of ACE, it is likely that mechanical stress leads 
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to an increase in Ang II and its pathologic effects.32 We observed a correlation 
between aortic diameter and α-2 spectrin cleavage (see supplemental material). 
Since mechanical or wall stress increases with aortic diameter, elevated calpain 
activity may be the result of augmented wall stress.  
Nearly 50% of patients with BAV develop a dilatation of the ascending aorta or aortic 
sinus.33 The mechanism remains controversial; genetic predisposition seems to play 
an important role in the initiation of aortic dilation rather than aberrant post-valvular 
hemodynamics.34-36 Histological changes in dilated aortic media share similarities 
with those seen in MFS, including increased VSMC apoptosis, cystic medial 
necrosis, elastin fragmentation and up-regulation of MMP-2.37-39 Histological 
parallels, together with presumed genetic defects of the extracellular matrix, lead us 
to assume that calpain is also activated in BAV. Indeed, our results present evidence 
that FlnA and spectrin cleavage increase to a similar extend in MFS when compared 
to controls. Therefore, increased calpain activity is a feature of both syndromes and 
suggests that BAV-associated aortic dilation is pathogenetically closer to that in MFS 
than previously assumed. To analyze, if the same holds true for conditions such as 
age and hypertension associated vascular ectasia with tricuspid valves, we 
examined calpain activity in this additional group and observed further increased 
spectrin cleavage (see supplemental material). Since hypertension is another cause 
of wall stress, we achieved further evidence that wall stress may increase calpain 
activity by possibly elevation of tissue Ang II and may further lead to abnormal 
vascular remodelling.    
Using 2D-DIGE, we observed up-regulation of four additional proteins in MFS 
aneurysm. The actin binding molecules vinculin and calponin were more highly 
expressed in the MFS group compared to controls. Vinculin is a membrane-
cytoskeletal protein stabilizing focal adhesions and suppressing cell migration.40 Up-
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regulation of the protein in smooth muscle cells was observed upon mechanical 
stretch.41 Calponins are up-regulated in mechanically stretched VSMC, partially by 
the action of Rho-associated kinase.42 Calponin 1 might therefore be involved in the 
regulation and modulation of smooth muscle cell contraction and act as a signal for 
cell differentiation.43 The MFS aneurysm is associated with increased levels of TGF-
β and, interestingly, stimulation of VSMC with TGF-β increases calponin 1.44, 45 
Therefore, the up-regulation of calponin 1 could be an indirect marker of increased 
TGF-β signalling. We observed two different types of calponin-1, accounting for the 
full length protein (33 kDa) and a fragment thereof (20kDa).  In analogy to FlnA, 
calponins can be cleaved by calpain.46  
Another observation was the up-regulation of MFAP 4 in aortic dilation. MFAP 4 is a 
29kDa elastin binding protein and plays a role in elastogenesis.47 Furthermore, 
MFAP 4 has high sequence homology to the aortic-aneurysm-associated protein-40, 
which has been found in human abdominal aortic aneurysm.48 Although not much is 
known about MFAP 4, there are indications that it might play an important role in 
aneurysm formation.  
Furthermore, we found up-regulation of the cellular myosin-10. It has been reported 
that Myo10 creates links between microtubules and the actin cytoskeleton as well as 
between integrins and the cytoskeleton.49, 50 Myo10 over expression is associated 
with an increased number of filopodia, which are important for cell migration. It is 
difficult to attribute a function to Myo10 in the context of MFS. Since aneurysm 
formation is in part an inflammatory process it possibly leads to increased migration 
of VSMC.  
 
Limitations of the Study 
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First, the proteome of aortic media consists of an enormous number of different 
proteins and two subsequent protein separation techniques are not feasible to 
separate all of them in a satisfactory manner. Additionally the dynamic range of 
protein expression spans seven or eight orders of magnitude. Furthermore, proteins 
within a given proteome are structurally diverse and present various physicochemical 
characteristics. Some of these proteins are alkaline or hydrophobic, are of poor 
solubility or have different staining characteristics. Therefore, the present study in the 
proteome of aortic aneurysm in MFS revealed interesting protein expression 
changes, but it could never detect them all. Second, results of proteomic studies 
have to be validated with an alternative method as we did using Western blot 
technology. Since our interest was the FlnA C-terminal fragment and its proteolysis, 
we did not validate the other proteins discussed here. Third, ELISA and zymography 
are two additional methods of confirming calpain up-regulation. Since samples of 
human aortic media are a rare and quantity is limited, further calpain confirmation 
could not be performed. Fourth, control subjects were in general older than MFS 
patients and calpain is known to be up-regulated in the aging.13 However in the 
present study, calpain was up-regulated in younger MFS patients and we therefore 
did not consider this finding to be biased by differences in age. 
 
Conclusions 
Using proteomic techniques, we identified up-regulation of the FlnA C-terminal 
fragment in aortic media of MFS patients suffering from aneurysm of the ascending 
aorta. We further observed indicators of increased TGF-β signalling and enhanced 
mechanical stress in MFS aortic aneurysm. Elevated FlnA cleavage was a result of 
higher calpain activity in MFS as well as in BAV patients. Increased FlnA 
fragmentation and elevated calpain activity have been shown to play a role in Ang II 
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induced vascular remodelling. Elevated calpain activity in aortic aneurysms may be 
the result of increased aortic wall stress. Pharmacological inhibition of calpain might 
prevent uncontrolled proteolysis and further signalling. Since the development of 
calpain inhibitors has been rather complicated AT1R blockers are the preferred 
approach for normalizing calpain activity in aortic media of MFS and BAV patients. 
Further research in the field of serum FlnA and spectrin fragmentation in MFS and 
BAV patients might present evidence for them to serve as potential serum 
biomarkers.  
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FIGURE LEGENDS 
Figure 1: Histology and separation of aortic tissue for proteomic analysis. Van 
Gieson’s elastic stain of aorta from representative control (A-C) and aneurismal aorta 
from MFS (D-F) and BAV patient (G-I). Aorta from MFS presents fragmentation of 
elastic fibres and thickened aortic wall (4x magnification). Intima with media (A, D, 
G), separated media (B, E, H), media with adventitia (C, F, I).  
 
Figure 2: Representative gel of separated aortic media proteins and 3D-images of 
protein spots. Proteins were differentially labelled with fluorescent dyes (Cy2, Cy3 
and Cy5) prior to separation by 2D-gel electrophoresis. Proteins up-regulated in MFS 
aneurysms appear in red, down-regulated proteins in green and those with equal 
expression appear in yellow. Arrows point to protein spots that showed significant 
changes in expression over all 6 gels. Red arrows indicate up-regulated proteins, 
blue arrows show down-regulated spots. Numbered spots have been identified and 
are explained in Table 1 and Table I of the online-only Data Supplement. 3D-images 
emphasise the differences in protein quantity on the example of the filamin A 
isoforms.  
 
Figure 3: Filamin A cleavage analysis. FlnA cleavage was increased in aortic 
specimens from MFS and bicuspid valve patients relative to controls. Representative 
Western blot showing full length FlnA at 280kDa and C-terminal fragments at 110 
and 90kDa (right). Mean ± SEM, *P<0.05, **P<0.005.  
 
Figure 4: Spectrin cleavage analysis. Cleavage of α-2 spectrin was significantly 
increased in MFS and BAV patients compared to controls (A) and correlated with 
cleavage of FlnA (B). Representative Western blot shows full length protein at 
  25 
240kDa and cleavage fragments at 145/150kDa (C). MFS (●), BAV (▲) and control 
patients (○). Mean ± SEM,*P<0.05, **P<0.005. 
 
Figure 5: Calpain 2 and calpastatin analysis. Increasing cleavage of filamin A 
correlates with increasing calpain 2 expression (A) and decreasing calpastatin 
expression (D). Cleavage of spectrin and therewith calpain activity correlates in a 
similar manner (B, E). The ratio between calpain 2 and calpastatin strongly 
correlates with filamin A (G) and α-2 spectrin cleavage (H). Representative Western 
blots showing calpain 2 (C) and calpastatin 2 (F). MFS (●), BAV (▲) and control 
patients (○). Dashed lines indicate the 95% confidence interval. 
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SUPPLEMENTAL MATERIAL 
 
Supplemental Methods 
 
 2D - Gel Electrophoresis. Aortic media was powderized and dissolved in 
differential gel electrophoresis buffer (DIGE) according to the manufacturer’s 
instructions (GE Healthcare, Buckinghamshire, UK). DNA was sheared using 
sonification. Equal amounts of aortic samples (50µg) from MFS patients and controls 
were labeled with Cy3 dye and Cy5 dye respectively. To guarantee uniform labeling, 
Cy3 and Cy5 were inverted in half of the patients. The internal standard containing 
equal amounts of protein of each sample was tagged with Cy2 dye. Labeled protein 
samples were pooled (MFS media, control media and internal standard) and 150µg 
loaded onto an immobilized pH gradient (IPG) dry strip with a non-linear pH range of 
pH 3-11 (GE Healthcare). After isoelectric focusing (total 73kVh), the IPG strips were 
equilibrated with dithiothreitol and iodoacetamide equilibration buffer sequentially 
according to the manufacturers instructions for 15min. The second dimension was 
conducted with a 12,5% SDS-polyacrylamide gel electrophoresis at 0.03 W/cm for 6 
hours. 6 gels were run simultaneously.  
 
 Mass Spectrometry. Colloidal Coomassie staining was used to visualize 
protein spots for spot picking. Individual and visible spots were cut from the gel and 
in-gel digested overnight with 10ng/µl trypsin in 50mM NH4HCO3 (Promega, 
Madison, USA). Extracted peptides were desalted using Zip Tips (Millipore, Billerica, 
USA) and analyzed by Matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-MS) and MALDI-MS/MS using an Ultraflex TOF/TOF II 
 2 
equipped with the control and analysis software Compass v.1.1 (Bruker Daltonics, 
Bremen, Germany). Combined MS and MS/MS spectra were used to search the 
Uniref100 database (release 6.0) using MASCOT software v.2.0 (Matrix Science, 
London, UK). Probability-based MASCOT scores greater than 62 were considered to 
be significant and not a random event (p<0.05). Samples which could not be 
identified by MALDI-MS/MS were subjected to liquid chromatography (LC) – LTQ 
OrbitrapTM (Thermo Scientific, Bremen, Germany). MS/MS peak lists were generated 
using Mascot Distiller (Matrix Science, London, UK) and used to search the 
Uniref100 database (release 6.0) using MASCOT software v. 2.0. 
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 7 
Subgroup analysis. . Calpain 2 activity assessed as spectrin cleavage was not 
higher in hypertensive (N=14) compared to normotensive (N=32) patients 
(hypertensive: 0.82±0.12, normotensive: 1.02±0.07, p=0.13). The same result was 
found when the subpopulations in the control, MFS and BAV group were analysed 
separately (data not shown). 
 
 
 
Supplemental Figure I: Correlations analysis between aortic diameter and α-2 
spectrin cleavage. Spectrin cleavage correlated significantly with increasing aortic 
diameter. MFS (●), BAV (▲) and control patients (○). Dashed lines indicate the 95% 
confidence interval. 
 
 
 
 
 8 
 
Supplemental Table III: α-2 Spectrin and Filamin A cleavage in ascending aortic 
aneurysms. 
 Controls MFS BAV TAV* P (TAV vs 
controls) 
N 15 22 9 18  
α-2 Spectrin cleavage 0.70±0.08 1.05±0.09 1.15±0.10 1.56±0.08 <0.0001 
Filamin A cleavage 2.04±0.21 2.64±0.17 3.04±0.21 5.89±0.47 <0.0001 
 
*TAV: Aortic aneurysm from patients with tricuspid aortic valve and without Marfan 
syndrome (N=18, gender: 72±11% male, mean age: 66±3 years, mean aortic 
diameter: 5.1±0.2cm, AT1 receptor blockers or ACE inhibitors: 56%, beta-blockers: 
78%).  
